Summary

The United States specialty generics market reached a value of US$ 21 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.

Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.

Report Scope:

Historical, Current and Future Market Trends

Market Breakup by Route of Administration:

Injectables
Oral
Others

Market Breakup by Therapeutic Application:

Oncology
Hepatitis
Multiple Sclerosis
HIV
Other Autoimmune Diseases
Others

Market Breakup by Distribution channel:

Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies

Competitive Landscape:

The leading players in the US specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:

How has the US specialty generics market performed so far and how will it perform in the coming years?
What is the breakup of the US specialty generics market based on the route of administration?
What has been the impact of COVID-19 on the US specialty generics market?
What is the breakup of the US specialty generics market based on the therapeutic application?
What is the breakup of the US specialty generics market based on the distribution channel?
What are the various stages in the value chain of the US specialty generics industry?
What are the key driving factors and challenges in the US specialty generics market?
What is the structure of the US specialty generics industry and who are the key players?
What is the degree of competition in the US specialty generics market?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Specialty Generics Market: Introduction
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics
5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Therapeutic Application
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast
7 US Specialty Generics Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Route of Administration
7.5 Market Breakup by Therapeutic Application
7.6 Market Breakup by Distribution Channel
7.7 Market Forecast
7.8 SWOT Analysis
7.8.1 Overview
7.8.2 Strengths
7.8.3 Weaknesses
7.8.4 Opportunities
7.8.5 Threats
7.9 Value Chain Analysis
7.10 Porters Five Forces Analysis
7.10.1 Overview
7.10.2 Bargaining Power of Buyers
7.10.3 Bargaining Power of Suppliers
7.10.4 Degree of Competition
7.10.5 Threat of New Entrants
7.10.6 Threat of Substitutes
7.11 Key Market Drivers and Success Factors
8 Market Breakup by Route of Administration
8.1 Injectables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.1 Market Forecast
9 Market Breakup by Therapeutic Application
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hepatitis
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Multiple Sclerosis
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 HIV
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Other Autoimmune Diseases
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players

List of Figures

Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 3: Global: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2020
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: US: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 8: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 9: US: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2020
Figure 10: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 11: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 12: US: Specialty Generics Industry: SWOT Analysis
Figure 13: US: Specialty Generics Industry: Value Chain Analysis
Figure 14: US: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 15: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2015 & 2020
Figure 16: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2015 & 2020
Figure 18: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2015 & 2020
Figure 20: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2015 & 2020
Figure 22: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: US: Specialty Generics Market (Hepatitis): Sales Value (in Million US$), 2015 & 2020
Figure 24: US: Specialty Generics Market (Hepatitis) Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: US: Specialty Generics Market (Multiple Sclerosis): Sales Value (in Million US$), 2015 & 2020
Figure 26: US: Specialty Generics Market (Multiple Sclerosis) Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: US: Specialty Generics Market (HIV): Sales Value (in Million US$), 2015 & 2020
Figure 28: US: Specialty Generics Market (HIV) Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: US: Specialty Generics Market (Other Autoimmune Diseases): Sales Value (in Million US$), 2015 & 2020
Figure 30: US: Specialty Generics Market (Other Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: US: Specialty Generics Market (Other Applications): Sales Value (in Million US$), 2015 & 2020
Figure 32: US: Specialty Generics Market (Other Applications) Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: US: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2015 & 2020
Figure 34: US: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2021-2026
Figure 35: US: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2015 & 2020
Figure 36: US: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2021-2026
Figure 37: US: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2015 & 2020
Figure 38: US: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2021-2026

List of Tables

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 2: US: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: US: Specialty Generics Market Forecast: Breakup by Therapeutic Application (in Million US$), 2021-2026
Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: US: Specialty Generics Market: Competitive Structure
Table 7: US: Specialty Generics Market: Key Players